ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics announced the publication of the highly anticipated results on the first 2000 patients tested, in the journal Genetics in Medicine, supporting the clinical adoption of multigene cancer panels in the diagnosis of hereditary cancer predisposition.
Help employers find you! Check out all the jobs and post your resume.
